Meet the Researcher Leading NIH’s COVID-19 Vaccine Development EffortsPosted on July 9th, 2020 by Dr. Francis CollinsA safe, effective vaccine is the ultimate tool needed to end the coronavirus disease 2019 (COVID-19) pandemic. So, I couldn’t think of a better person to give us a quick overview of the COVID-19 vaccine research landscape than NIH’s Dr. John Mascola, who is Director of the VRC. There’s a general principle in vaccine development: if the immune system generates neutralizing antibodies, that’s a very good sign. Does that mean their immune system only saw a little bit of the viral antigen and didn’t respond very robustly? What’s your most optimistic view about when we might have a COVID-19 vaccine that’s safe and effective enough to distribute to the public?
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.